WallStSmart

Andersen Group Inc. (ANDG)vsMEDIFAST INC (MED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Andersen Group Inc. generates 152% more annual revenue ($871.37M vs $346.10M). MED leads profitability with a -5.8% profit margin vs -6.0%. MED earns a higher WallStSmart Score of 45/100 (D).

ANDG

Avoid

32

out of 100

Grade: F

Growth: 6.7Profit: 4.0Value: 5.0Quality: 5.0
Piotroski: 2/9Altman Z: 1.95

MED

Hold

45

out of 100

Grade: D

Growth: 2.0Profit: 2.0Value: 6.0Quality: 8.5
Piotroski: 2/9Altman Z: 4.98

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ANDG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
15.7%8/10

15.7% revenue growth

MED4 strengths · Avg: 9.5/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.9810/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.978/10

Growing faster than its price suggests

Areas to Watch

ANDG4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.954/10

Grey zone — moderate risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-182.6%2/10

ROE of -182.6% — below average capital efficiency

MED4 concerns · Avg: 2.5/10
Market CapQuality
$134.54M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-10.1%2/10

ROE of -10.1% — below average capital efficiency

Revenue GrowthGrowth
-34.3%2/10

Revenue declined 34.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : ANDG

The strongest argument for ANDG centers on Revenue Growth. Revenue growth of 15.7% demonstrates continued momentum.

Bull Case : MED

The strongest argument for MED centers on Price/Book, Debt/Equity, Altman Z-Score. PEG of 0.97 suggests the stock is reasonably priced for its growth.

Bear Case : ANDG

The primary concerns for ANDG are EPS Growth, Altman Z-Score, Piotroski F-Score. Debt-to-equity of 15.63 is elevated, increasing financial risk.

Bear Case : MED

The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

ANDG profiles as a growth stock while MED is a turnaround play — different risk/reward profiles.

ANDG is growing revenue faster at 15.7% — sustainability is the question.

MED generates stronger free cash flow (-836,000), providing more financial flexibility.

Monitor PERSONAL SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MED scores higher overall (45/100 vs 32/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Andersen Group Inc.

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Andersen Group Inc. provides independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States.

MEDIFAST INC

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.

Visit Website →

Want to dig deeper into these stocks?